Sleep Apnea Prevalent Among Cardio-Oncology Patients
By Elana Gotkine HealthDay Reporter
MONDAY, Feb. 12, 2024 -- Sleep apnea is prevalent among 35 percent of cardio-oncology patients, and those with untreated sleep apnea have significantly abnormal Global Longitudinal Left Ventricular (LV) Strain (GLS), according to a study presented at the Advancing the Cardiovascular Care of the Oncology Patient conference organized by the American College of Cardiology and held from Feb. 9 to 11 in Washington, D.C.
Mini K. Das, M.D., from Baptism Health in Louisville, Kentucky, and colleagues collected data from 296 general cardiology patients and 240 cardio-oncology patients to examine the prevalence and impact of sleep apnea.
The researchers found that the prevalence of sleep apnea was 54 percent in general cardiology patients and 35 percent among the cardio-oncology patients. In the cardio-oncology patients, sleep apnea prevalence was higher than several traditional risk factors used in cardiovascular risk stratification for cardiotoxicity. LV ejection fraction was relatively similar for patients with treated or untreated sleep apnea and for those with high scores on the Snoring, Tiredness, Observed apnea, elevated blood Pressure, Body mass index, Age, Neck, Gender (STOP-BANG) screening tool. Patients with untreated sleep apnea and patients with high STOP-BANG scores had significantly abnormal GLS.
"Sleep apnea should be incorporated into current risk algorithms and a larger study is needed to evaluate the impact of sleep apnea in this high-risk population," Das said in a statement. "We feel that sleep apnea assessment must be a part of routine risk assessment for patients undergoing cancer therapeutics."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Read this next
Heart Health Varies With Race Among Sexual-Minority Females
WEDNESDAY, May 1, 2024 -- For sexual-minority (SM) females, cardiovascular health (CVH) varies across race and ethnicity, according to a study published online May 1 in JAMA...
Healthy Lifestyle Can Overcome Genetic Predisposition to Premature Death
WEDNESDAY, May 1, 2024 -- Adherence to healthy lifestyles can largely overcome the genetic risk for a shorter lifespan, according to a study published online April 29 in BMJ...
Brief Provocation of Anger Adversely Affects Endothelial Health
WEDNESDAY, May 1, 2024 -- A brief provocation of anger has an adverse effect on endothelial cell health, according to a study published online May 1 in the Journal of the American...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.